Skip to main navigation Skip to search Skip to main content

Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine

2 Citations (Scopus)
Original languageEnglish
JournalHeadache
Volume59
Issue number4
Pages (from-to)626
Number of pages1
ISSN0017-8748
DOIs
Publication statusPublished - 2019

Cite this